CP
AKRO icon

CenterBook Partners’s Akero Therapeutics AKRO Stock Holding History

CenterBook Partners’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-185,559
Closed -$8.81M – 550
2025
Q3 		$8.81M Buy
+185,559
New +$8.99M 0.44% 49

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

CenterBook Partners's AKRO Position: Q4 2025 in Review

CenterBook Partners sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 185,559 shares — an estimated $8.81M sold.

CenterBook Partners first reported a position in AKRO in Q3 2025 and held it in 1 quarter. The position peaked at $8.81M in Q3 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • CenterBook Partners reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • CenterBook Partners sold 185,559 Akero Therapeutics shares in Q4 2025, an estimated $8.81M.
  • CenterBook Partners first reported a position in Akero Therapeutics in Q3 2025 and held it in 1 quarter.
  • CenterBook Partners's Akero Therapeutics position peaked at $8.81M in Q3 2025.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on CenterBook Partners's 13F filing for Q4 2025, filed 11 Feb 2026.